SCHEMBL19205975

SCHEMBL19205975

CON(C(=O)OC(C)(C)C)c1ccc(F)c([N+](=O)[O-])c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.40
HIF1A Q16665 1/20 0.40
VCAM1 P19320 1/20 0.38
LMNA P02545 6/20 0.37
ITGB1 P05556 1/20 0.37
ITGA5 P08648 1/20 0.37
GAA P10253 2/20 0.37
PKM P14618 1/20 0.37
MEN1 O00255 4/20 0.37
KMT2A Q03164 4/20 0.37
HTT P42858 3/20 0.37
MAPT P10636 3/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
RECQL P46063 1/20 0.36
WDR5 P61964 1/20 0.35
NPSR1 Q6W5P4 2/20 0.35
ATM Q13315 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
PTGS2 P35354 1/20 0.34
CA1 P00915 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18147782 0.88 ALDH1A1 (0.43) ALDH1A1HIF1AVCAM1LMNAITGB1
SCHEMBL13077189 0.85 ALDH1A1 (0.42) ALDH1A1HIF1AVCAM1LMNAITGB1
SCHEMBL25877847 0.81 ALDH1A1 (0.39) ALDH1A1HIF1AVCAM1LMNAITGB1
SCHEMBL18146659 0.81 ATM (0.44) ALDH1A1HIF1ALMNAKMT2AHTT
SCHEMBL5285266 0.79 ALDH1A1 (0.45) ALDH1A1LMNAGAAMEN1KMT2A
SCHEMBL28573395 0.77 ITGB1 (0.38) ALDH1A1HIF1AVCAM1LMNAITGB1
SCHEMBL18154006 0.77 ATM (0.43) ALDH1A1LMNAMEN1KMT2AHTT
SCHEMBL6349781 0.77 MAPT (0.46) ALDH1A1LMNAPKMMEN1KMT2A
SCHEMBL18147065 0.76 ESPL1 (0.35) ALDH1A1HIF1AVCAM1LMNAITGB1
SCHEMBL18145878 0.76 ESPL1 (0.35) ALDH1A1HIF1AVCAM1LMNAITGB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170233395-A1 2,4-DISUBSTITUTED 7H-PYRROLO[2,3-D]PYRIMIDINE DERIVATIVE, PREPARATION METHOD AND MEDICINAL USE THEREOF YANGTZE RIVER PHARMACEUTICAL GROUP CO., LTD. (CN) 2017-08-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170233395-A1 2,4-DISUBSTITUTED 7H-PYRROLO[2,3-D]PYRIMIDINE DERIVATIVE, PREPARATION METHOD AND MEDICINAL USE THEREOF TYMP, TPMT, TYMS ALDH1A1 436/4885HIF1A 4045/4885VCAM1 4697/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.